Advanced search
Start date
Betweenand
(Reference retrieved automatically from Web of Science through information on FAPESP grant and its corresponding number as mentioned in the publication by the authors.)

Development to Term of Cloned Cattle Derived from Donor Cells Treated with Valproic Acid

Full text
Author(s):
Sangalli, Juliano Rodrigues [1, 2, 3] ; Chiaratti, Marcos Roberto [3, 4] ; Camara De Bem, Tiago Henrique [5, 2] ; de Araujo, Reno Roldi [2, 3] ; Bressan, Fabiana Fernandes [2] ; Sampaio, Rafael Vilar [1, 2, 3] ; Perecin, Felipe [2] ; Smith, Lawrence Charles [6] ; King, Willian Allan [1] ; Meirelles, Flavio Vieira [2]
Total Authors: 10
Affiliation:
[1] Univ Guelph, Ontario Vet Coll, Dept Biomed Sci, Guelph, ON N1G 2W1 - Canada
[2] Univ Sao Paulo, Fac Zootecnia & Engn Alimentos, Dept Vet Med, Sao Paulo - Brazil
[3] Univ Sao Paulo, Fac Med Vet & Zootecnia, Dept Cirurgia, Sao Paulo - Brazil
[4] Univ Fed Sao Carlos, Ctr Ciencias Biol & Saude, Dept Genet & Evolucao, BR-13560 Sao Carlos, SP - Brazil
[5] Univ Sao Paulo, Fac Med Ribeirao Preto, Dept Genet, Sao Paulo - Brazil
[6] Univ Montreal, Fac Med Vet, Ctr Rech Reprod Anim, St Hyacinthe, PQ J2S 7C6 - Canada
Total Affiliations: 6
Document type: Journal article
Source: PLoS One; v. 9, n. 6 JUN 24 2014.
Web of Science Citations: 26
Abstract

Cloning of mammals by somatic cell nuclear transfer (SCNT) is still plagued by low efficiency. The epigenetic modifications established during cellular differentiation are a major factor determining this low efficiency as they act as epigenetic barriers restricting reprogramming of somatic nuclei. In this regard, most factors that promote chromatin decondensation, including histone deacetylase inhibitors (HDACis), have been found to increase nuclear reprogramming efficiency, making their use common to improve SCNT rates. Herein we used valproic acid (VPA) in SCNT to test whether the treatment of nuclear donor cells with this HDACi improves pre- and post-implantation development of cloned cattle. We found that the treatment of fibroblasts with VPA increased histone acetylation without affecting DNA methylation. Moreover, the treatment with VPA resulted in increased expression of IGF2R and PPARGC1A, but not of POU5F1. However, when treated cells were used as nuclear donors no difference of histone acetylation was found after oocyte reconstruction compared to the use of untreated cells. Moreover, shortly after artificial activation the histone acetylation levels were decreased in the embryos produced with VPA-treated cells. With respect to developmental rates, the use of treated cells as donors resulted in no difference during pre-and post-implantation development. In total, five clones developed to term; three produced with untreated cells and two with VPA-treated cells. Among the calves from treated group, one stillborn calf was delivered at day 270 of gestation whereas the other one was delivered at term but died shortly after birth. Among the calves from the control group, one died seven days after birth whereas the other two are still alive and healthy. Altogether, these results show that in spite of the alterations in fibroblasts resulting from the treatment with VPA, their use as donor cells in SCNT did not improve pre- and post-implantation development of cloned cattle. (AU)

FAPESP's process: 10/19768-8 - Epigenetic regulation of IGF2R gene in cattle
Grantee:Felipe Perecin
Support type: Regular Research Grants
FAPESP's process: 13/06673-7 - Use of histones deacetylases inhibitors in bovine somatic cell nuclear transfer.
Grantee:Juliano Rodrigues Sangalli
Support type: Scholarships in Brazil - Doctorate
FAPESP's process: 10/13384-3 - Effect of introducing embryonic or somatic mitochondria on development and on mitochondrial inheritance in cattle
Grantee:Flávio Vieira Meirelles
Support type: Regular Research Grants